Literature DB >> 2981674

Human pancreatic growth hormone-releasing factor-44 differentially stimulates release of stored and newly synthesized rat growth hormone in vitro.

M E Stachura, J M Tyler, P K Farmer.   

Abstract

Effects of synthetic human pancreatic GH-releasing factor-44 (hpGRF-44) on synthesis and release of rat pituitary GH and PRL were examined in vitro in a static incubation system. A double label, specific immunoprecipitation protocol permitted simultaneous study of hormone synthesis as well as release of both stored and newly synthesized hormone. Synthetic hpGRF-44 (0.3 and 3.0 nM) stimulated the release of stored GH 240% beyond the basal level, while simultaneously stimulating the release of newly synthesized GH by 610%. Despite the stimulation of release, hpGRF-44 did not alter GH synthesis (102% of control value). A small but statistically significant increase in release of stored PRL occurred in response to hpGRF-44, while release of newly synthesized PRL and PRL synthesis were unaffected. In contrast, 1 mM (Bu)2cAMP stimulated the release of both newly synthesized and stored GH and PRL. We conclude that hpGRF-44 differentially stimulates GH release from separate intracellular compartments and that the lactotroph may also, under certain conditions, respond to this secretagogue.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981674     DOI: 10.1210/endo-116-2-698

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  7 in total

1.  GHRH-test in short children with "non classic" GH deficiency. A comparison with "classic" GH deficiency and short normal stature.

Authors:  G Saggese; G Cesaretti; N Giannessi; L Cinquanta; C Bracaloni; C Cioni; G Di Spigno; R Di Porto
Journal:  J Endocrinol Invest       Date:  1990-06       Impact factor: 4.256

2.  Growth hormone and prolactin responses to bolus and sustained infusions of GRH-1-40-OH in man.

Authors:  J A Goldman; M E Molitch; M O Thorner; W Vale; J Rivier; S Reichlin
Journal:  J Endocrinol Invest       Date:  1987-08       Impact factor: 4.256

3.  Plasma growth hormone (GH) responses to corticotropin-releasing hormone in patients with acromegaly--the effect of dexamethasone pretreatment and the comparison with GH responses to thyrotropin-releasing hormone, gonadotropin-releasing hormone and GH-releasing hormone.

Authors:  A Utsumi; K Hanew; A Sugawara; Y Shimizu; O Murakami; H Ikeda; K Yoshinaga
Journal:  J Endocrinol Invest       Date:  1992-03       Impact factor: 4.256

4.  Medium flow rate modulates autocrine-paracrine feedback of GH and PRL release by perifused GH3 cells.

Authors:  M E Stachura; C A Lapp; J M Tyler; Y S Lee
Journal:  In Vitro Cell Dev Biol       Date:  1990-05

5.  Autocrine-paracrine inhibition of growth hormone and prolactin production by GH3 cell-conditioned medium.

Authors:  C A Lapp; J M Tyler; Y S Lee; M E Stachura
Journal:  In Vitro Cell Dev Biol       Date:  1989-06

6.  GH3 cell secretion of growth hormone and prolactin increases spontaneously during perifusion.

Authors:  C A Lapp; M E Stachura; J M Tyler; Y S Lee
Journal:  In Vitro Cell Dev Biol       Date:  1987-10

7.  Comparison of stress-induced changes in adults and pups: is aldosterone the main adrenocortical stress hormone during the perinatal period in rats?

Authors:  János Varga; Szilamér Ferenczi; Krisztina J Kovács; Alexandra Garafova; Daniela Jezova; Dóra Zelena
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.